Sun Pharmaceutical Recalls Riomet

News
Article

The company is recalling product because of microbial contamination.

Sun Pharmaceutical Industries, Inc. announced on Nov. 24, 2017 that it was voluntarily recalling two lots of Riomet (Metformin Hydrochloride Oral Solution), 500 mg/5mL because Scopulariopsis brevicaulis was found during testing. The recalled lots were manufactured by a contract manufacturer. The company discovered the contamination during sample preparation for the antimicrobial preservative effectiveness testing, which was performed as part of the 12-month stability study interval.

Riomet is used to treat type 2 diabetes mellitus in adults and children over 10. While the company has not yet received any complaints of adverse events, use of contaminated product could cause infection, pneumonia, and sinusitis.

The recalled lots are NDC Code 10631-206-01 Lot A160031A, with an expiration date of 01/2018, and NDC 10631-206-02 Lot: A160031B, with an expiration date of 01/2018. The lots were distributed nationwide to wholesale customers.

Source: FDA

Recent Videos
Roger Viney from ICE Pharma discusses the quality and compliance issues surrounding the use of animal-derived ingredients in the bio/pharma industry.
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.